Jie Jun Wong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jie Jun Wong has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Angela S. Koh
Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore
13 shared publications Ru-San Tan
National Heart Centre Singapore
8 shared publicationsFei Gao
Department of Cardiology, National Heart Centre Singapore, Singapore; Duke-NUS Medical School, Singapore
5 shared publications- Fei Gao
Department of Cardiology, National Heart Centre, Singapore, Singapore
3 shared publications - Jonathan Yap
National Heart Centre Singapore
3 shared publications - Khung Keong Yeo
National Heart Center Singapore, Singapore, Singapore
3 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
Environmental Sustainability and Equity in Healthcare Research: A Strategic Review of the Asia-Pacific Landscape
The healthcare industry accounts for a substantial share of global greenhouse gas emissions, and clinical research contributes significantly to this footprint through carbon-intensive operations. The Asia-Pacific region is a key global research hub and must balance rapid industrial growth with necessary environmental protection. Systemic barriers, including regulatory fragmentation, geographical logistical complexities and energy inequities contribute to a reliance on traditional carbon-intensive research models. Creating a resilient scientific ecosystem requires a move toward a growth model where sustainability drives economic stability and health security. This article examines strategies to align regional regulatory standards and integrate sustainability into healthcare governance through strategic leadership and collaboration, regulatory convergence, incentivising green research and promoting sustainable methodologies. It also outlines ways in which the environmental footprint of medical innovation and healthcare delivery in the Asia-Pacific region might be recognised and reduced.
- 8 September 2026
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
Open AccessEnvironmental Sustainability and Equity in Healthcare Research: A Strategic Review of the Asia-Pacific Landscape
The healthcare industry accounts for a substantial share of global greenhouse gas emissions, and clinical research contributes significantly to this footprint through carbon-intensive operations. The Asia-Pacific region is a key global research hub and must balance rapid industrial growth with necessary environmental protection. Systemic barriers, including regulatory fragmentation, geographical logistical complexities and energy inequities contribute to a reliance on traditional carbon-intensive research models. Creating a resilient scientific ecosystem requires a move toward a growth model where sustainability drives economic stability and health security. This article examines strategies to align regional regulatory standards and integrate sustainability into healthcare governance through strategic leadership and collaboration, regulatory convergence, incentivising green research and promoting sustainable methodologies. It also outlines ways in which the environmental footprint of medical innovation and healthcare delivery in the Asia-Pacific region might be recognised and reduced.
- 19 June 2026
- Published by Springer Nature in Phenomics
- Vol. 6 (5) , 724-739
Associations between Lipoprotein Subclasses and Cardiovascular Function in Ageing
- 19 June 2026
- Published by Springer Nature in Phenomics
- Vol. 6 (5) , 724-739
Associations between Lipoprotein Subclasses and Cardiovascular Function in Ageing
- 1 January 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 330 (1) , H278-H287
Sex-based differences and determinants of right ventricular function and right ventricular-pulmonary arterial adaptations in older adults
Our study used cardiovascular magnetic resonance to examine sex-based differences in right ventricular function and right ventricular-pulmonary arterial (RV-PA) coupling in 255 healthy older adults. Women had smaller right ventricular volumes but demonstrated higher ejection fraction, superior myocardial strain, and stronger RV-PA coupling compared with men. These findings highlight distinct hemodynamic adaptations of the aging right heart, suggesting that sex-specific reference values may be needed to differentiate physiological variation from early pathological changes.
- 1 January 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 330 (1) , H278-H287
Sex-based differences and determinants of right ventricular function and right ventricular-pulmonary arterial adaptations in older adults
Our study used cardiovascular magnetic resonance to examine sex-based differences in right ventricular function and right ventricular-pulmonary arterial (RV-PA) coupling in 255 healthy older adults. Women had smaller right ventricular volumes but demonstrated higher ejection fraction, superior myocardial strain, and stronger RV-PA coupling compared with men. These findings highlight distinct hemodynamic adaptations of the aging right heart, suggesting that sex-specific reference values may be needed to differentiate physiological variation from early pathological changes.
- Open Access
- 3 December 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (11) , 102278
Incorporating Implementation Science Into Frailty Interventions for Cardiovascular Disease
- 3 December 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (11) , 102278
Open AccessIncorporating Implementation Science Into Frailty Interventions for Cardiovascular Disease
- Open Access
- 8 October 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 4
Advancing Cardiovascular Sciences in Ageing for Cardiovascular Longevity Through Transformation and Implementation
Population ageing and the rise in age-related cardiovascular disease are major sources of healthcare, societal and economic stress worldwide. Cardiovascular disease often coincides with declines in other organ systems, resulting in functional dependence, cognitive impairment, sarcopenia, and frailty. Despite substantial gerontology and cardiovascular research advancements, further efforts are needed in clinical care, translation, education, and health policy. To effectively address the growing challenges of ageing and cardiovascular disease in the authors’ region, centralised institutions focused on discovering, translating and implementing scientifically backed strategies are urgently needed. We envision that the transformation of cardiovascular care of older adults should encompass the full spectrum of primary prevention at the population health level to secondary prevention and the maintenance of healthy longevity. This notion could take the form of a cardiovascular ageing and longevity initiative, the first of its kind within the Asia-Pacific cardiology community, that will transform the landscape of geriatric cardiology through translating discoveries in cardiovascular geroscience and advancing gerontechnology innovations for real-world applications.
- 8 October 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 4
Open AccessAdvancing Cardiovascular Sciences in Ageing for Cardiovascular Longevity Through Transformation and Implementation
Population ageing and the rise in age-related cardiovascular disease are major sources of healthcare, societal and economic stress worldwide. Cardiovascular disease often coincides with declines in other organ systems, resulting in functional dependence, cognitive impairment, sarcopenia, and frailty. Despite substantial gerontology and cardiovascular research advancements, further efforts are needed in clinical care, translation, education, and health policy. To effectively address the growing challenges of ageing and cardiovascular disease in the authors’ region, centralised institutions focused on discovering, translating and implementing scientifically backed strategies are urgently needed. We envision that the transformation of cardiovascular care of older adults should encompass the full spectrum of primary prevention at the population health level to secondary prevention and the maintenance of healthy longevity. This notion could take the form of a cardiovascular ageing and longevity initiative, the first of its kind within the Asia-Pacific cardiology community, that will transform the landscape of geriatric cardiology through translating discoveries in cardiovascular geroscience and advancing gerontechnology innovations for real-world applications.
- Open Access
- 5 September 2025
- Published by Elsevier in JACC: Asia
- Vol. 5 (11) , 1457-1471
Addressing Frailty in Cardiology
- 5 September 2025
- Published by Elsevier in JACC: Asia
- Vol. 5 (11) , 1457-1471
Open AccessAddressing Frailty in Cardiology
- Open Access
- 22 August 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (9) , 102097
Sex-Dependent Effects of Body Fat on Cardiac Function and Outcomes in Community-Dwelling Older Adults
- 22 August 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (9) , 102097
Open AccessSex-Dependent Effects of Body Fat on Cardiac Function and Outcomes in Community-Dwelling Older Adults
- Open Access
- 23 June 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (7) , 101889
Effect of Frailty on Cardiovascular Clinical Trials
- 23 June 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (7) , 101889
Open AccessEffect of Frailty on Cardiovascular Clinical Trials
- Open Access
- 13 January 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Imaging Methods and Practice
- Vol. 3 (1) , qyaf075
Superior aortic strain and ventriculoarterial coupling in older women are moderately correlated with Framingham 10-year risk
Aims: Traditional risk factors do not fully characterize cardiovascular aging and are less helpful in assessing sex differences in cardiovascular risk. Using a novel cardiovascular magnetic resonance (CMR) method, we determined sex differences in aortic global longitudinal strain (AOGLS) and ventriculoarterial coupling (VAC) with correlations to Framingham risk scores. Methods and results: Community older adults without cardiovascular disease underwent CMR. AOGLS was the maximal absolute Lagrangian strain between the brachiocephalic artery and aortic annulus. VAC was aortic pulse wave velocity (AAPWV) divided by LVGLS. Among 202 participants (46.0% female, 70.2 ± 8.8 years), women had lower diastolic blood pressure (DBP) (70.5 ± 10.8 mmHg vs. 78.1 ± 9.5 mmHg, P < 0.001), body surface area (BSA) (1.52 ± 0.12 m2 vs. 1.70 ± 0.14 m2, P < 0.001), and fewer smokers (3.2% vs. 25.7% P < 0.001) than men, despite similar ages. Women had better AAPWV (8.41 ± 2.73 m/s vs. 9.13 ± 3.18 m/s, adj. P = 0.020), AOGLS (6.16 ± 2.44% vs. 5.21 ± 1.74%, adj. P = 0.030), LVGLS (−21.93 ± 2.59 vs. −20.06 ± 2.79%, adj. P = 0.021), VAC (−0.39 ± 0.15 vs. −0.47 ± 0.21, adj. P = 0.006), and smaller indexed cardiac volumes. Female sex was associated with better AOGLS (β = 0.838, adj. P = 0.030; R2 = 0.103) and VAC (β = −0.093, adj. P = 0.006; R2 = 0.113) independent of smoking, DBP, and BSA. Among women, AOGLS was moderately correlated with 10-year risks (r = −0.400 P = <0.001) and VAC was associated with 10-year risks (β = −6.915, adj. P = 0.017; R2 = 0.145). Conclusion: Novel CMR-derived aortic longitudinal strain differentiated ventriculo-aortic aging between the sexes. Women had superior AOGLS and VAC, independent of body size and DBP, that correlated better with Framingham risk scores compared to men. Impaired AOGLS and VAC may be useful in differentiating individuals at intermediate from low-borderline cardiovascular risk. Trial registration: ClinicalTrials.gov Identifier: NCT02791139
- 13 January 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Imaging Methods and Practice
- Vol. 3 (1) , qyaf075
Open AccessSuperior aortic strain and ventriculoarterial coupling in older women are moderately correlated with Framingham 10-year risk
Aims: Traditional risk factors do not fully characterize cardiovascular aging and are less helpful in assessing sex differences in cardiovascular risk. Using a novel cardiovascular magnetic resonance (CMR) method, we determined sex differences in aortic global longitudinal strain (AOGLS) and ventriculoarterial coupling (VAC) with correlations to Framingham risk scores. Methods and results: Community older adults without cardiovascular disease underwent CMR. AOGLS was the maximal absolute Lagrangian strain between the brachiocephalic artery and aortic annulus. VAC was aortic pulse wave velocity (AAPWV) divided by LVGLS. Among 202 participants (46.0% female, 70.2 ± 8.8 years), women had lower diastolic blood pressure (DBP) (70.5 ± 10.8 mmHg vs. 78.1 ± 9.5 mmHg, P < 0.001), body surface area (BSA) (1.52 ± 0.12 m2 vs. 1.70 ± 0.14 m2, P < 0.001), and fewer smokers (3.2% vs. 25.7% P < 0.001) than men, despite similar ages. Women had better AAPWV (8.41 ± 2.73 m/s vs. 9.13 ± 3.18 m/s, adj. P = 0.020), AOGLS (6.16 ± 2.44% vs. 5.21 ± 1.74%, adj. P = 0.030), LVGLS (−21.93 ± 2.59 vs. −20.06 ± 2.79%, adj. P = 0.021), VAC (−0.39 ± 0.15 vs. −0.47 ± 0.21, adj. P = 0.006), and smaller indexed cardiac volumes. Female sex was associated with better AOGLS (β = 0.838, adj. P = 0.030; R2 = 0.103) and VAC (β = −0.093, adj. P = 0.006; R2 = 0.113) independent of smoking, DBP, and BSA. Among women, AOGLS was moderately correlated with 10-year risks (r = −0.400 P = <0.001) and VAC was associated with 10-year risks (β = −6.915, adj. P = 0.017; R2 = 0.145). Conclusion: Novel CMR-derived aortic longitudinal strain differentiated ventriculo-aortic aging between the sexes. Women had superior AOGLS and VAC, independent of body size and DBP, that correlated better with Framingham risk scores compared to men. Impaired AOGLS and VAC may be useful in differentiating individuals at intermediate from low-borderline cardiovascular risk. Trial registration: ClinicalTrials.gov Identifier: NCT02791139
- 3 January 2025
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (9) , 2667-2684
The GLOB-cAGE consortium: a global cardiovascular collaborative network of older adults with cardiovascular disease
The Global Cardiovascular Collaborative Network of Older Adults with Cardiovascular Disease (GLOB-cAGE) is a newly established, unprecedented consortium that brings together cohorts of older individuals with cardiovascular disease (CVD) worldwide. The GLOB-cAGE aims to harmonize nonidentifiable data from longitudinal cohorts examining cardiovascular health and CVD diagnosis and management in older individuals to perform meta-regression analyses using combined repositories of standardized subject-level data points. Studies registered into GLOB-cAGE are population-based longitudinal cohort studies or clinical trials, either ongoing or completed, that involve assessing cardiovascular health as a central objective. Cross-sectional studies that significantly contribute to cardiovascular research in older individuals may also be included. The GLOB-cAGE will consist of individuals already diagnosed with CVD and primary prevention of individuals at different risks of CVD. The studies should have a minimum sample size of 100 participants, and the participants are either adults older than 65 years or older than 40 years with longitudinal follow-up over the next few decades. Enrollment in GLOB-cAGE may involve collaboration on nonidentifiable or anonymized raw or processed data for joint analyses. Sites unable to provide raw or processed data due to institutional or other reasons may participate in alternative ways, including performing separate analyses in-house. At the time of writing, there are at least 10 participating teams from 9 countries and 27 studies enrolled in GLOB-cAGE. The GLOB-cAGE consortium is an international effort to bring together CVD research in older individuals, focusing on providing greater representation from diverse countries battling population aging. It addresses the evidence gaps from the insufficient enrolment of older individuals in randomized controlled trials and permits investigators to conduct high-quality epidemiologic studies. This article is part of a Special Collection on Cross-National Gerontology.
- 3 January 2025
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (9) , 2667-2684
The GLOB-cAGE consortium: a global cardiovascular collaborative network of older adults with cardiovascular disease
The Global Cardiovascular Collaborative Network of Older Adults with Cardiovascular Disease (GLOB-cAGE) is a newly established, unprecedented consortium that brings together cohorts of older individuals with cardiovascular disease (CVD) worldwide. The GLOB-cAGE aims to harmonize nonidentifiable data from longitudinal cohorts examining cardiovascular health and CVD diagnosis and management in older individuals to perform meta-regression analyses using combined repositories of standardized subject-level data points. Studies registered into GLOB-cAGE are population-based longitudinal cohort studies or clinical trials, either ongoing or completed, that involve assessing cardiovascular health as a central objective. Cross-sectional studies that significantly contribute to cardiovascular research in older individuals may also be included. The GLOB-cAGE will consist of individuals already diagnosed with CVD and primary prevention of individuals at different risks of CVD. The studies should have a minimum sample size of 100 participants, and the participants are either adults older than 65 years or older than 40 years with longitudinal follow-up over the next few decades. Enrollment in GLOB-cAGE may involve collaboration on nonidentifiable or anonymized raw or processed data for joint analyses. Sites unable to provide raw or processed data due to institutional or other reasons may participate in alternative ways, including performing separate analyses in-house. At the time of writing, there are at least 10 participating teams from 9 countries and 27 studies enrolled in GLOB-cAGE. The GLOB-cAGE consortium is an international effort to bring together CVD research in older individuals, focusing on providing greater representation from diverse countries battling population aging. It addresses the evidence gaps from the insufficient enrolment of older individuals in randomized controlled trials and permits investigators to conduct high-quality epidemiologic studies. This article is part of a Special Collection on Cross-National Gerontology.